drug protocol number

MK0431-263

drug sponsor

MSD

drug study

Sitagliptin

drug trial site

Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Al-Hada), King Fahad University Hospital (Al-Khobar), Riyadh Care Hospital, Al Alam Medical Center (Riyadh)

drug status

Completed

drug phase